Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Her is my answer from Hawk on the Royalty payment question

Great posts this morning. I agree with you on everything posted.

When Pohl was the CEO there was more clarity and PTSC put a better spin on PR's for shareholders and investors. Now it seems the company is falling all over itself trying to keep information from shareholders and investors. When a company is in trouble it seems like they really pump the PR's. PTSC is not doing this and do very little to sell investors on the only real product they have the MMP. Why are they keeping us in the dark?

Most of us own about as many or more shares than the BOD's. Is that because some of them are waiting for an even lower share price to buy shares? RG bought a good chunk but with his crudentials that's probably wallet money for him.

Why is it we can't get clear straight forward answers to questions that don't affect the NDA's?

The USPTO review should be the last major roadblock. Hopfully the company has plans to open up communication then. RG could clear up a few things in his next letter to shareholders if he wanted to IMO.

All the best,

Steve

Share
New Message
Please login to post a reply